See also
this year's filing and
all EDGAR filings for this company.
PDF Report 0001642380_2023_Oncocyte_Corp.pdf
Logs
info |
Added remainder_ComprehensiveNetIncome directly from 10K |
industry.us_generic |
{} |
Graph
Absolute values for 0001642380, Oncocyte Corp
|
xvar |
xval |
0 |
LiabilitiesNoncurrent |
0 |
1 |
LiabilitiesCurrent |
12,106,000 |
2 |
remainder_Liabilities |
48,391,000 |
3 |
AssetsCurrent |
25,536,000 |
4 |
AssetsNoncurrent |
371,000 |
5 |
PropertyPlantAndEquipmentNet |
0 |
6 |
Goodwill |
61,633,000 |
7 |
remainder_Assets |
12,551,000 |
8 |
GeneralAndAdministrativeExpense |
23,893,000 |
9 |
ResearchAndDevelopmentExpense |
7,301,000 |
10 |
remainder_Expenses |
-12,239,000 |
11 |
remainder_Revenues |
958,000 |
12 |
remainder_NetIncome |
-54,905,000 |
13 |
remainder_ComprehensiveNetIncome |
2,000 |
|
yvar |
yval |
0 |
Liabilities |
60,497,000 |
1 |
Assets |
100,091,000 |
2 |
Expenses |
18,955,000 |
3 |
Revenues |
958,000 |
4 |
StockholdersEquity |
39,594,000 |
5 |
NetIncome |
-72,902,000 |
6 |
ComprehensiveNetIncome |
-72,901,000 |
7 |
BaseVar |
117,704,000 |
8 |
EconomicCapitalRatio |
-0.489 |
Edgar->Model Mapping
Feature Distribution
Change over Time